Su, V. Y., Yang, K., Huang, T., Hsu, C., Chen, Y., Yen, J., . . . He, C. (2020). The efficacy of first-line tyrosine kinase inhibitors combined with co-medications in Asian patients with EGFR mutation non-small cell lung cancer. Sci Rep.
Stile di citazione ChicagoSu, Vincent Yi-Fong, Kuang-Yao Yang, Ting-Yu Huang, Chia-Chen Hsu, Yuh-Min Chen, Jiin-Cherng Yen, Yueh-Ching Chou, Yuh-Lih Chang, e Chien-Hui He. "The Efficacy of First-line Tyrosine Kinase Inhibitors Combined With Co-medications in Asian Patients With EGFR Mutation Non-small Cell Lung Cancer." Sci Rep 2020.
Citazione MLASu, Vincent Yi-Fong, et al. "The Efficacy of First-line Tyrosine Kinase Inhibitors Combined With Co-medications in Asian Patients With EGFR Mutation Non-small Cell Lung Cancer." Sci Rep 2020.